NCT02540226View on ClinicalTrials.gov

Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Intravenous tranexamic acid

DRUG

Topical tranexamic acid

DRUG

Intravenous saline

DRUG

Topical saline

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors

lead

Hospital for Special Surgery, New York

OTHER

NCT02540226 - Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement | Biotech Hunter | Biotech Hunter